Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes-Reference-Cited by-同舟云学术

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes

Published:2007-07 Issue:3 Volume:422 Page:228-231
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Kiferle Lorenzo,Ceravolo Roberto,Petrozzi Lucia,Rossi Carlo,Frosini Daniela,Rocchi Anna,Siciliano Gabriele,Bonuccelli Ubaldo,Murri Luigi

Publisher

Elsevier BV

Subject

General Neuroscience

Reference33 articles.

1. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease;Aarsland;Arch. Neurol.,1999

2. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies;Ballard;Ann. Neurol.,2000

3. Association analysis between the C516T polymorphism in the 5-HT2A receptor gene and schizophrenia;Bertola;Arq. Neuropsiquiatr.,2007

4. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series;Bullock;Curr. Med. Res. Opin.,2004

5. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders;Collier;Mol Psychiatry,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychosis in Parkinson’s Disease: A Lesson from Genetics;Genes;2022-06-20

2. Association analysis of serotonin system gene polymorphisms (5-HTT, HTR1B, HTR2A, HTR2C, and TPH1) with the risk of Parkinson's disease in Tatars;Yakut Medical Journal;2021

3. Mécanisme d’action de la pimavansérine : le nouvel antipsychotique pour traiter la psychose parkinsonienne;Annales Médico-psychologiques, revue psychiatrique;2019-12

4. Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson Disease;Clinical Neuropharmacology;2017-11

5. A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease;BMC Medical Genomics;2017-09-19